Potential Biomarker, Drug Target ID’d for Adult Leukemia Prophylactic rFIXFc, administered every one to two weeks, resulted in low annualized bleeding rates in patients with hemophilia B. (HealthDay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback